CompanyNasdaqBothell, WA

Biolife Solutions INC

SEC EDGAR ClinicalTrials.gov

SCHEDULE 13GSep 24Latest SEC filing

Form DOct 27$10M sold

August 2026

BioLife Solutions posts Q2 2026 results as Repligen acquisition heads toward Q4 close

Aug 6Quarterly updateBiolife Solutions INC

BioLife shares employee video from Repligen CEO on pending merger

Aug 3PeopleBiolife Solutions INC

July 2026

Repligen to acquire BioLife Solutions for about $1.5 billion

Jul 22M&ABiolife Solutions INC